DiaMedica Therapeutics, Inc. (DMAC)
6.39
-0.36
(-5.33%)
USD |
NASDAQ |
Aug 28, 16:00
6.39
0.00 (0.00%)
After-Hours: 20:00
DiaMedica Therapeutics Debt to Equity Ratio : 0.0048 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0048 |
| March 31, 2026 | 0.0045 |
| December 31, 2025 | 0.0043 |
| September 30, 2025 | 0.0052 |
| June 30, 2025 | 0.0107 |
| March 31, 2025 | 0.0093 |
| December 31, 2024 | 0.0084 |
| September 30, 2024 | 0.0076 |
| June 30, 2024 | 0.0073 |
| March 31, 2024 | 0.0082 |
| December 31, 2023 | 0.0078 |
| September 30, 2023 | 0.0076 |
| June 30, 2023 | 0.0074 |
| March 31, 2023 | 0.017 |
| December 31, 2022 | 0.0147 |
| September 30, 2022 | 0.0131 |
| June 30, 2022 | 0.0007 |
| March 31, 2022 | 0.0011 |
| December 31, 2021 | 0.0012 |
| September 30, 2021 | 0.0014 |
| June 30, 2021 | 0.0042 |
| March 31, 2021 | 0.0044 |
| December 31, 2020 | 0.0045 |
| September 30, 2020 | 0.0045 |
| June 30, 2020 | 0.0131 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0122 |
| December 31, 2019 | 0.0234 |
| September 30, 2019 | 0.0196 |
| June 30, 2019 | 0.0173 |
| March 31, 2019 | 0.0156 |
| December 31, 2018 | |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -0.4059 |
| December 31, 2015 | -0.5285 |
| September 30, 2015 | -0.6082 |
| June 30, 2015 | -0.9416 |
| March 31, 2015 | -0.7396 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 45.00M |
| Total Liabilities (Quarterly) | 6.663M |
| Shareholders Equity (Quarterly) | 38.34M |
| Current Ratio | 6.720 |
| Net Debt Paydown Yield | 0.01% |